
Join to view full profile
125 Paterson StDivision of RheumatologyNew Brunswick, NJ 08901
Phone+1 732-235-6583
Fax+1 732-235-6526
Dr. Sloan is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Victor Sloan is a distinguished pharmaceutical executive, clinical expert, and public health leader with more than 25 years of experience in immunology, drug development, and global health initiatives. Spanning both the private and public sectors, his extensive career combines a deep understanding of immunologic and related disorders with extensive managerial experience and a track record of driving organizational and clinical innovation. Victor has been instrumental in developing medical solutions and fostering cross-functional collaboration to improve patient outcomes and public health resilience.
Education & Training
University of California (San Francisco)Fellowship, Rheumatology, 1993 - 1994
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1989 - 1991
New York Medical CollegeClass of 1989
Certifications & Licensure
CA State Medical License 1992 - Present
NJ State Medical License 1994 - 2027
PA State Medical License 1996 - 1998
NY State Medical License 1990 - 1996
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity EMR, GE Healthcare, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Centricity EMR, GE Healthcare, 2014, 2016-2017
- Fellow (FACP) American College of Physicians, 2004
Clinical Trials
Publications & Presentations
PubMed
- The Trial.Victor S Sloan, Lois Wingerson, Christopher Adams
The Journal of Rheumatology. 2025-03-01 - Putting Patients First.Victor S Sloan
The Journal of Rheumatology. 2024-07-01 - 5 citationsOpioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases.Anna Sheahan, Suzanne Anjohrin, Robert Suruki, Jeffrey L Stark, Victor S Sloan
Clinical Rheumatology. 2024-06-01
Press Mentions
Congress Must Lower Health Care Costs for NJ Patients | OpinionDecember 5th, 2025
Chronic Opioid Use May Be Common in Patients with Ankylosing SpondylitisJune 11th, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









